Preclinical Research

Mission Bio raises $70m to help develop cancer therapies

17-Aug-2020 By Jenni Spinner

The company has landed $70m in Series C funding, with the purpose of accelerating development of cancer therapies with single-cell multiomics.

People on the Move: August 2020

04-Aug-2020 By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

Research partnership delves into opioid alternatives

03-Aug-2020 By Jenni Spinner

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

Thermo Fischer Scientific backs 200+ COVID-19 projects globally

28-Jul-2020 By Jenni Spinner

The company is offering technology and support to projects around the world seeking to discover and produce vaccines and therapeutics.

Lonza: the right bio model can make a difference

27-Jul-2020 By Jenni Spinner

A leader from the health solutions and technology company explains how the proper biological models can enhance drug discovery and development.

Aigenpulse launches AI-based discovery platform

20-Jul-2020 By Jenni Spinner

The company is introducing technology using artificial intelligence and machine learning to accelerate drug discovery and development.

Health ‘ecosystem’ brings research, technology together

16-Jul-2020 By Jenni Spinner

An innovation-minded nonprofit organization aims to foster collaboration among scientists and tech minds, to fuel discovery and accelerate therapies.

Latest FDA advice and actions on COVID-19

15-Jul-2020 By Jenni Spinner

As the virus behind the pandemic continues to impact the globe, the federal agency continues to offer advice and take action in response to the virus.

Dewpoint and Merck in $305m deal for HIV ‘cure’

14-Jul-2020 By Ben Hargreaves

The two partners will use Dewpoint’s platform, focusing on biomolecular condensates, to treat the disease.

A-Alpha Bio lands Gates Foundation drug development grant

13-Jul-2020 By Jenni Spinner

The $800K grant will fund development of therapeutics for infectious diseases, including respiratory viruses like COVID-19, using machine learning.

Vantiq, RoviSys: COVID-19 shows need for advanced pharma tech

06-Jul-2020 By Jenni Spinner

Two leaders from advanced tech firms share lessons learned during the pandemic, pointing toward a need for technology to drive the future of pharma.

This week’s FDA COVID-19 news

02-Jul-2020 By Jenni Spinner

The agency continues to offer advice for drug developers and other stakeholders, and to take action against companies that step out of line.

Thermo Scientific workflow aims to accelerate drug development

29-Jun-2020 By Jenni Spinner

The iSPA Workflow, using single-particle analysis technology, is intended to help pharmaceutical bring drugs to market faster while conserving costs.

Berg harnesses Oak Ridge supercomputer in COVID-19 fight

18-Jun-2020 By Jenni Spinner

The company will be using the Oak Ridge National Laboratory Summit supercomputer to explore potential vaccines and treatments for the deadly virus

Adaptive Biotechnologies: AI can ‘translate’ immune system

27-May-2020 By Jenni Spinner

The company is putting artificial intelligence to work in the hopes of coming up with more precise, effective tests and therapies for a range of diseases.